The Global Market for Infusion Pumps is Projected to Reach US$13.0 Billion by 2022

Rise in Chronic Diseases & Shift Towards Home Care Drive the Global Infusion Pumps Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Infusion Pumps market. The global market for Infusion Pumps is projected to reach US$13.0 billion by 2022, driven by the rise in incidence and prevalence of chronic diseases, migration of treatment towards home care settings, and improving healthcare infrastructure in emerging markets.

Infusion pumps are widely used in healthcare settings for enabling easy administration of nutrients and medications  such as pain relievers, insulin, antibiotics, and chemotherapy drugs in accordance with patient requirements. Owing to their user-friendly features, ergonomic design, high reliability and ability to allow patients to move during the treatment process, infusion pumps find growing acceptance, especially across home care settings. Further, the emergence of novel drugs that require sophisticated delivery mechanisms and the daunting task to reduce medical injuries due to infusion errors are also expanding the application scope of infusion pumps globally. Rising number of patients requiring continuous intravenous (IV) administration of drugs also supports growth of these medical devices. Broad macro trends that influence market growth include aging population; rise in chronic conditions such as AIDS, cancer, type 1 diabetes, gastrointestinal diseases, neurological conditions and malnutrition; rise in healthcare spending, and development of the healthcare infrastructure, among others. Implementation of a number of government initiatives for reducing the healthcare cost related to extended hospital stays is likely to push up the penetration of infusion systems within home care applications.

The market continues to remain under pressure over device safety issues. Concerns over device reliability and infusion errors have spiraled following the recent spate of product recalls. Manufacturers are boosting equipment reliability through the development of new software incorporated with wireless enhancements, safety alarms, and operating logs that would bring down medication error rates, and would provide improved quality of care to patients.  Future growth in syringe pumps and electronic pain management pumps will be driven by developments in chemotherapy drugs, shift towards alternate care, and equipment upgrades. Insulin infusion pumps have been recording immense growth due to the rise in the number of Type 1 diabetes cases. Sales in the category are largely driven by cutting edge innovations, such as smart insulin pumps incorporated with glucose monitors and meters and easy to apply pump sets. Rise in pre-term births as a result of growing number of lifestyle-associated diseases continue to drive demand for enteral feeding pumps.

As stated by the new market research report on Infusion pumps, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 7.4% over the analysis period, led by factors such as large patient population; increasing incidence of diabetes, cancer and gastrointestinal diseases; growing disposable incomes; and rising focus on healthcare infrastructure development.

Major players covered in the report include Animas Corporation, Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Halyard Health Inc., Hospira Inc., ICU Medical Inc., Insulet Corporation, Medtronic Plc, Moog Inc., Smiths Medical, Sooil Development Co. Ltd., Tandem Diabetes Care Inc., Teleflex Incorporated, and Terumo Corporation, among others.

The research report titled “Infusion Pumps: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe) Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America) and Rest of World. The report analyses the global and regional markets by the following Product Segments - Ambulatory Infusion Pumps, Enteral Feeding Pumps, Insulin Infusion Pumps, Large Volume Infusion Pumps, PCA Infusion Pumps, and Syringe Infusion Pumps.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.